de Melker HE - Search Results

1

Transmissibility of SARS-CoV-2 among fully vaccinated individuals.

Knol MJ, Backer JA, de Melker HE, van den Hof S, Gier B. Knol MJ, et al. Among authors: de melker he. Lancet Infect Dis. 2022 Jan;22(1):16-17. doi: 10.1016/S1473-3099(21)00763-5. Lancet Infect Dis. 2022. PMID: 34953541 Free PMC article. No abstract available.

2

A population-based study on tetanus antitoxin levels in The Netherlands.

de Melker HE, van den Hof S, Berbers GA, Nagelkerke NJ, Rümke HC, Conyn-van Spaendonck MA. de Melker HE, et al. Vaccine. 1999 Aug 20;18(1-2):100-8. doi: 10.1016/s0264-410x(99)00186-3. Vaccine. 1999. PMID: 10501240

3

Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination.

de Haas R, van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA. de Haas R, et al. Among authors: de melker he. Epidemiol Infect. 1999 Oct;123(2):263-70. doi: 10.1017/s0950268899002939. Epidemiol Infect. 1999. PMID: 10579446 Free PMC article.

4

Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage.

van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA. van den Hof S, et al. Among authors: de melker he. Vaccine. 1999 Dec 10;18(9-10):931-40. doi: 10.1016/s0264-410x(99)00348-5. Vaccine. 1999. PMID: 10580207

5

The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey.

Termorshuizen F, Dorigo-Zetsma JW, de Melker HE, van den Hof S, Conyn-Van Spaendonck MA. Termorshuizen F, et al. Among authors: de melker he. Epidemiol Infect. 2000 Jun;124(3):459-66. doi: 10.1017/s0950268899003842. Epidemiol Infect. 2000. PMID: 10982070 Free PMC article.

6

Antibodies to Haemophilus influenzae serotype b in the Netherlands a few years after the introduction of routine vaccination.

van Den Hof S, de Melker HE, Berbers GA, van Der Kraak PH, Spaendonck MA. van Den Hof S, et al. Among authors: de melker he. Clin Infect Dis. 2001 Jan;32(1):2-8. doi: 10.1086/317538. Epub 2000 Dec 12. Clin Infect Dis. 2001. PMID: 11118384

7

The seroepidemiology of measles in Western Europe.

de Melker H, Pebody RG, Edmunds WJ, Lévy-Bruhl D, Valle M, Rota MC, Salmaso S, van den Hof S, Berbers G, Saliou P, Spaendonck MCV, Crovari P, Davidkin I, Gabutti G, Hesketh L, Morgan-Capner P, Plesner AM, Raux M, Tische A, Miller E. de Melker H, et al. Epidemiol Infect. 2001 Apr;126(2):249-59. doi: 10.1017/s0950268801005234. Epidemiol Infect. 2001. PMID: 11349976 Free PMC article.

8

Measles outbreak in a community with very low vaccine coverage, the Netherlands.

van den Hof S, Meffre CM, Conyn-van Spaendonck MA, Woonink F, de Melker HE, van Binnendijk RS. van den Hof S, et al. Among authors: de melker he. Emerg Infect Dis. 2001;7(3 Suppl):593-7. doi: 10.3201/eid0707.010743. Emerg Infect Dis. 2001. PMID: 11485681 Free PMC article.

9

Hospitalizations during a measles epidemic in the Netherlands, 1999 to 2000.

Van Den Hof S, Smit C, Van Steenbergen JE, De Melker HE. Van Den Hof S, et al. Among authors: de melker he. Pediatr Infect Dis J. 2002 Dec;21(12):1146-50. doi: 10.1097/00006454-200212000-00012. Pediatr Infect Dis J. 2002. PMID: 12488666

10

Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b.

de Melker HE, van den Hof S, Berbers GA, Conyn-van Spaendonck MA. de Melker HE, et al. Vaccine. 2003 Jan 30;21(7-8):716-20. doi: 10.1016/s0264-410x(02)00587-x. Vaccine. 2003. PMID: 12531347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

296 results

Search Page